Tagged Articles

Fresenius Medical Care 64 articles

Judge calls for more information from those suing Fresenius

People who want their day in court over alleged injuries caused by Fresenius Medical Care’s dialysis drugs must first provide more information about their claims including expert certifications, said senior U.S. District Judge Douglas P. Woodlock. Woodlock pulled the so-called Lone Pine order to weed out meritless claims and to encourage a settlement with the stronger cases that remain. About 12,000 cases are pending in the multidistrict litigation (MDL) against Fresenius. The lawsuits claim that Fresenius’ dialysis concentrates GranuFlo and NaturaLyte caused toxic levels of bicarbonate in the blood of dialysis patients, which caused patients to suffer heart attacks and ... Read More

Plaintiffs fight back against Fresenius motion to dismiss GranuFlo lawsuits

Attorneys representing plaintiffs in a multidistrict litigation (MDL) against dialysis giant Fresenius Medical Care over potentially fatal cardiac effects with the company’s GranuFlo and NaturaLyte dialysis products told a judge that hundreds of Massachusetts and Mississippi cases are eligible to join the MDL because there is no proof that patients or their doctors knew about a 2012 FDA warning regarding the products. Fresenius filed a motion to toss out hundreds of cases in the MDL because they were filed three years after the FDA warning, which issued on May 25, 2012. “Defendants pin their hopes on a single FDA safety ... Read More

Study focuses on reducing sudden cardiac death in dialysis patients

Patients with end-stage kidney disease are at high risk of sudden cardiac death when they begin dialysis treatment. A team of researchers with the University of Rochester Medical Center are conducting the largest clinical study of its kind focused on reducing sudden death in dialysis patients. Sudden cardiac death is the single largest cause of death in dialysis patients, occurring in about a quarter of dialysis patients. It is defined by a sudden and unexpected death caused by loss of heart function. Dialysis is a treatment that filters the blood to rid the body of harmful waste and extra salt ... Read More

Fresenius slapped with wrongful death lawsuit

A man is suing Fresenius Medical Care and others, claiming negligence on behalf of the dialysis company and members of Huntington Internal Medicine Group in Huntington, W. Va., which he claims caused injuries and the premature death of his father. John. E. Bourdelais was undergoing dialysis treatment under the care of the defendants on July 13, 2013, when he suffered life-threatening injuries including hemorrhagic shock, cardiopulmonary arrest, bilateral pleural effusions, cardiac arrhythmias, hypovolemic arrest, traumatic hemothorax and multiple fractured ribs secondary to resuscitation. This, the lawsuit claims, shortened his life by two years. The lawsuit was filed by John M. ... Read More

Dialysis products GranuFlo, NaturaLyte linked to sudden cardiac arrest

Attorneys with Beasley Allen Law Firm are investigating cases of cardiac events including sudden cardiac arrest in patients who underwent dialysis treatment in which GranuFlo or NaturaLyte concentrates were used. GranuFlo and NaturaLyte are used to balance electrolytes in patients undergoing dialysis treatment. They are made by Fresenius Medical Care, and are used in both Fresenius-owned and non-Fresenius-owned dialysis clinics. The products metabolize into a substance called bicarbonate within the body. Elevated levels of bicarbonate can cause heart problems including heart attacks, sudden cardiac arrest, and death. Fresenius became aware that the dosing instructions printed on labels of GranuFlo and ... Read More

Fresenius faces lawsuits alleging injury, death from defective dialysis products

Lawsuits were filed against Fresenius Medical Care in a Kentucky circuit court on behalf of the estates of 11 people, alleging the company’s dry acid dialysis products were defective and caused patients injuries and death. Fresenius is the world’s largest provider of dialysis products and services. The company supplies dry acid concentrates GranuFlo and NaturaLyte to both Fresenius-owned and non-Fresenius-owned dialysis clinics. The products are used during dialysis to help maintain proper electrolyte levels. Both GranuFlo and NaturaLyte contain an ingredient that metabolizes in the body to bicarbonate. Too much bicarbonate in the blood can cause cardiovascular problems including sudden ... Read More

Lawsuit claims Fresenius dialysis product caused man’s death

A Mississippi woman is suing Fresenius Medical Care claiming the dialysis provider gave her husband a lethal dose of a dialysis product that caused him to suffer a fatal cardiovascular event. Marshall Russell Phillips was undergoing dialysis at a treatment center in Brandon, Miss., during which he was administered NaturaLyte and/or GranuFlo dialysis products. The dialysis concentrates are used to help balance electrolytes in patients undergoing dialysis. Fresenius, a world leader in dialysis products and services, manufactures NaturaLyte and GranuFlo and distributes it to both Fresenius-owned and non-Fresenius-owned dialysis clinics. In 2012, the company discovered that the dosing instructions on the ... Read More

The Fraud List: Fresenius Medical Care milks Medicaid with dialysis empire

The Fraud List

Fresenius Medical Care is the largest provider of kidney dialysis services and products in the U.S. The company’s North America division treats more than 170,000 patients in 2,200 dialysis clinics located in 50 states and territories. Many of Fresenius patients are Medicare beneficiaries who require dialysis to treat end-stage kidney disease and other chronic illnesses, which means that the company submits several thousand reimbursement claims to the Medicare program every year. On May 26, 2011, federal authorities announced a settlement between Fresenius, its affiliated companies, and the U.S. government, which underscored how fraud became almost institutionalized, reaching into the upper levels of ... Read More

Fresenius dialysis product recall shuts down only clinic in American Samoa

American Samoa’s only dialysis clinic was shut down for two days last week after workers were notified that one of its dialysis concentrates was recalled due to possible bacterial contamination. There were no other concentrates available, and dialysis patients were forced to wait until dialysis products provider Fresenius Medical Care could ship replacement concentrates to this small island about 2,300 miles south of Hawaii. Dialysis is a life saving process during which machines filter the blood of patients whose kidneys no longer function properly. Patients generally require about three to four dialysis treatments per week. Going more than three or ... Read More

Study reveals more dialysis patient deaths occur in winter months

Dialysis patients are more likely to die during winter months, according to a study presented at the European Renal Association-European Dialysis and Transplant Association’s 52nd congress held in London. The study was a retrospective cohort conducted by researchers with the Medical University of Graz, Austria, and involved nearly 2,500 dialysis patients. During the study, 1,836 patients died. Data revealed that all-cause mortality was highest in winter, with 1.60 deaths per 100 patient-months, and lowest in summer, with 1.06 deaths per patient months. The findings are similar to a U.S. study conducted by researchers with the Renal Research Institute in New ... Read More